Hot Features
プレミアム
Recursion Pharmaceuticals Inc (RXRX)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 144.80k | Derivative Exercise and Sale | 3.62 | 300.44k | - |
| 2026-06-05 | Dr. Najat KhanCEO, President & Director | -23.59k | 84.46k | Automatic Disposition | 3.58 | 108.54k | -17.85% |
| 2026-06-02 | Dr. Blake C. BorgesonIndependent Director | -30.00k | 110.40k | Automatic Disposition | 3.68 | 6.15M | -0.49% |
| 2026-06-03 | Dr. Namandje N. BumpusIndependent Director | -4.39k | 15.53k | Automatic Disposition | 3.54 | 43.17k | -9.22% |
| 2026-05-22 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 123.20k | Derivative Exercise and Sale | 3.08 | 300.44k | - |
| 2026-05-15 | Mr. Ben R. TaylorCFO & President of Recursion UK | -25.02k | 76.05k | Sale to Issuer | 3.04 | 285.58k | -8.05% |
| 2026-05-15 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -22.82k | 69.38k | Sale to Issuer | 3.04 | 300.44k | -7.06% |
| 2026-05-15 | Dr. David HallettChief Scientific Officer | -26.66k | 81.04k | Sale to Issuer | 3.04 | 406.65k | -6.15% |
| 2026-05-15 | Dr. Najat KhanCEO, President & Director | -62.70k | 190.61k | Sale to Issuer | 3.04 | 132.13k | -32.18% |
| 2026-05-07 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -60.00k | 134.80k | Derivative Exercise and Sale | 3.37 | 244.17k | - |
| 2026-05-05 | Dr. Blake C. BorgesonIndependent Director | -30.00k | 105.60k | Automatic Disposition | 3.52 | 6.18M | -0.48% |
| 2026-04-22 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 144.40k | Derivative Exercise and Sale | 3.61 | 244.17k | - |
| 2026-04-06 | Mr. Ben R. TaylorCFO & President of Recursion UK | -48.03k | 149.37k | Sale to Issuer | 3.11 | 257.37k | -15.73% |
| 2026-04-07 | Dr. Blake C. BorgesonIndependent Director | -30.00k | 93.00k | Automatic Disposition | 3.10 | 6.21M | -0.48% |
| 2026-04-07 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 124.00k | Derivative Exercise and Sale | 3.10 | 244.17k | - |
| 2026-03-23 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 130.00k | Derivative Exercise and Sale | 3.25 | 244.17k | - |
| 2026-03-17 | Mr. Ben R. TaylorCFO & President of Recursion UK | -7.96k | 26.97k | Automatic Disposition | 3.39 | 203.21k | -3.77% |
| 2026-03-16 | Mr. Ben R. TaylorCFO & President of Recursion UK | -7.08k | 24.20k | Sale to Issuer | 3.42 | 203.21k | -3.36% |
| 2026-03-09 | Dr. Najat KhanCEO, President & Director | -28.30k | 94.66k | Automatic Disposition | 3.35 | 40.73k | -40.99% |
| 2026-03-09 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -20.00k | 0.00 | Derivative Exercise and Sale | - | 244.17k | - |
| 2026-03-03 | Dr. Blake C. BorgesonIndependent Director | -170.00k | 588.20k | 売り | 3.46 | 6.24M | -2.65% |
| 2026-02-17 | Dr. David HallettChief Scientific Officer | -11.91k | 41.56k | Sale to Issuer | 3.49 | 382.79k | -3.02% |
| 2026-02-18 | Mr. Ben R. TaylorCFO & President of Recursion UK | -13.43k | 41.35k | Automatic Disposition | 3.08 | 203.23k | -6.20% |
| 2026-02-17 | Mr. Ben R. TaylorCFO & President of Recursion UK | -11.91k | 41.56k | Sale to Issuer | 3.49 | 203.23k | -5.54% |
| 2026-02-19 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 138.40k | Derivative Exercise and Sale | 3.46 | 244.17k | - |
| 2026-02-17 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -27.27k | 95.15k | Sale to Issuer | 3.49 | 244.17k | -10.04% |
| 2026-02-17 | Dr. Najat KhanCEO, President & Director | -14.28k | 49.84k | Sale to Issuer | 3.49 | 69.03k | -17.14% |
| 2026-02-06 | Dr. David HallettChief Scientific Officer | -11.40k | 45.37k | Sale to Issuer | 3.98 | 300.78k | -3.65% |
| 2026-02-06 | Dr. Najat KhanCEO, President & Director | -10.36k | 41.25k | Sale to Issuer | 3.98 | 33.81k | -23.46% |
| 2026-02-06 | Mr. Ben R. TaylorCFO & President of Recursion UK | -11.40k | 45.37k | Sale to Issuer | 3.98 | 203.23k | -5.31% |
| 2026-02-03 | Dr. Blake C. BorgesonIndependent Director | -220.00k | 924.00k | Automatic Disposition | 4.20 | 6.41M | -3.32% |
| 2026-02-04 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 164.80k | Derivative Exercise and Sale | 4.12 | 179.33k | - |
| 2026-02-06 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -10.36k | 36.90k | Sale to Issuer | 3.56 | 179.33k | -5.46% |
| 2026-01-20 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 178.80k | Derivative Exercise and Sale | 4.47 | 159.35k | - |
| 2026-01-06 | Dr. Blake C. BorgesonIndependent Director | -220.00k | 959.20k | Automatic Disposition | 4.36 | 6.63M | -3.21% |
| 2026-01-05 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -60.00k | 170.00k | Derivative Exercise and Sale | 4.25 | 159.35k | - |
| 2025-12-29 | Mr. Ben R. TaylorCFO & President of Recursion UK | -21.38k | 89.38k | Automatic Disposition | 4.18 | 190.38k | -10.10% |
| 2025-12-22 | Dr. Najat KhanCEO, President & Director | -124.40k | 548.59k | Automatic Disposition | 4.41 | 13.83k | -90.00% |
| 2025-12-18 | Mubadala Investment Company PJSC法人 | -12.99M | 56.59M | 売り | 4.24 - 4.58 | 0.00 | -100.00% |
| 2025-12-19 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 180.00k | Derivative Exercise and Sale | 4.50 | 159.35k | - |
| 2025-12-15 | Mr. Ben R. TaylorCFO & President of Recursion UK | -7.06k | 30.56k | Sale to Issuer | 4.33 | 211.76k | -3.23% |
| 2025-12-04 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -60.00k | 185.20k | Derivative Exercise and Sale | 4.63 | 159.35k | - |
| 2025-12-02 | Dr. Blake C. BorgesonIndependent Director | -220.00k | 961.40k | Automatic Disposition | 4.37 | 6.85M | -3.11% |
| 2025-11-25 | Mr. Ben R. TaylorCFO & President of Recursion UK | -2.27k | 9.15k | Sale to Issuer | 4.03 | 203.81k | -1.10% |
| 2025-11-17 | Mr. Ben R. TaylorCFO & President of Recursion UK | -11.91k | 49.30k | Sale to Issuer | 4.14 | 201.25k | -5.59% |
| 2025-11-17 | Dr. Najat KhanCEO, President & Director | -17.58k | 72.80k | Sale to Issuer | 4.14 | 138.23k | -11.29% |
| 2025-11-19 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.00k | 166.40k | Derivative Exercise and Sale | 4.16 | 159.35k | - |
| 2025-11-17 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.39k | 167.21k | Sale to Issuer | 4.14 | 159.35k | -20.22% |
| 2025-11-04 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -60.00k | 208.40k | Derivative Exercise and Sale | 5.21 | 107.63k | - |
| 2025-10-23 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -100.00k | 570.00k | Derivative Exercise and Sale | 5.70 | 107.63k | - |
| 2025-10-10 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -120.00k | 604.00k | Derivative Exercise and Sale | 6.04 | 100.66k | - |
| 2025-09-25 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -100.00k | 476.00k | Derivative Exercise and Sale | 4.76 | 107.63k | - |
| 2025-09-15 | Mr. Ben R. TaylorCFO & President of Recursion UK | -7.06k | 34.09k | Sale to Issuer | 4.83 | 187.82k | -3.62% |
| 2025-09-10 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -120.00k | 471.00k | Derivative Exercise and Sale | 4.71 | 107.63k | - |
| 2025-08-26 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -100.00k | 484.00k | Derivative Exercise and Sale | 4.84 | 107.63k | - |
| 2025-08-18 | Dr. Najat KhanCEO, President & Director | -36.60k | 202.17k | 売り | 5.52 | 111.62k | -24.69% |
| 2025-08-15 | Dr. Najat KhanCEO, President & Director | -3.79k | 21.37k | Sale to Issuer | 5.64 | 111.62k | -3.28% |
| 2025-08-15 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -40.39k | 227.80k | Sale to Issuer | 5.64 | 107.63k | -27.29% |
| 2025-08-15 | Mr. Ben R. TaylorCFO & President of Recursion UK | -11.91k | 67.16k | Sale to Issuer | 5.64 | 179.86k | -6.21% |
| 2025-08-11 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -541.54k | 2.86M | Derivative Exercise and Sale | 5.28 | 55.91k | - |
| 2025-08-11 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -76.63k | 404.63k | Automatic Disposition | 5.28 | 55.91k | -57.82% |
| 2025-08-11 | Dr. Christopher C. GibsonCo-Founder, Chairman & Interim Executive Advisor | -10.00k | 0.00 | Other Disposition | - | 55.91k | -15.17% |
| 2025-06-16 | Mr. Ben R. TaylorCFO & President of Recursion UK | -7.06k | 34.72k | Sale to Issuer | 4.92 | 166.44k | -4.07% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
